Morgan Stanley Trans Medics Group, Inc. Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
A detailed history of Morgan Stanley transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Morgan Stanley holds 511,636 shares of TMDX stock, worth $80.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
511,636
Previous 444,907
15.0%
Holding current value
$80.3 Million
Previous $32.9 Million
134.26%
% of portfolio
0.01%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding TMDX
# of Institutions
358Shares Held
29.6MCall Options Held
399KPut Options Held
154K-
Black Rock Inc. New York, NY2.65MShares$415 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.53MShares$397 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.49MShares$233 Million2.41% of portfolio
-
Invesco Ltd. Atlanta, GA1.36MShares$214 Million0.04% of portfolio
-
Eventide Asset Management, LLC Boston, MA1.15MShares$180 Million3.04% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $5B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...